A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
Clinical trial NCT06844474 · RECRUITING
Trial details
- NCT number
- NCT06844474
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-07
- Primary completion
- 2026-08-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.